Create a narrative

DexCom Community

NasdaqGS:DXCM Community

1 Narratives written by author
1 Comments on narratives written by author
87 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 25 Analysts

New G7 And Stelo Launches Will Shape Future Markets

Key Takeaways Expansion of prescriber base and new over-the-counter CGM products are poised to boost revenue and improve net margins through wider market penetration. Coverage expansion by major PBMs and product advancements like the Dexcom G7 System are key revenue growth drivers, backed by a significant share repurchase program.

US$98.85

FV

10.0% undervalued

15.11%

Revenue growth p.a.

0

1

47

4 days ago